Pharmacokinetic equivalence study of two formulations of the anticonvulsant pregabalin

References

• SweetmanSCMartindale: The Complete Drug Reference36th edLondonPharmaceutical Press (PhP)2009
   Google Scholar
• American Society of Health-System PharmacistsMcEvoyGKSnowEKAHFS Drug Information 2013Bethesda, MarylandBoard of the American Society of Health-System Pharmacists2013
   Google Scholar
• FinnerupNBJensenTSClinical use of pregabalin in the management of central neuropathic painNeuropsychiatr Dis Treat20073688589119300623
   PubMedGoogle Scholar
• BlommelMLBlommelALPregabalin: an antiepileptic agent useful for neuropathic painAm J Health Syst Pharm200764141475148217617497
   PubMed Web of Science ®Google Scholar
• BockbraderHNBurgerPKnappLCorriganBWPopulation pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizuresEpilepsia201152224825721269291
   PubMed Web of Science ®Google Scholar
• Ben-MenachemEPregabalin pharmacology and its relevance to clinical practiceEpilepsia2004456131815315511
   PubMed Web of Science ®Google Scholar
• who.int [homepage on the Internet] Epilepsy Fact sheet number 999World Health Organization2015 [cited September 12, 2014]. Available from: http://www.who.int/mediacentre/factsheets/fs999/en/Accessed March 11, 2015
   Google Scholar
• Commission on Tropical Diseases of the International League against EpilepsyRelationship between epilepsy and tropical diseasesEpilepsia199435189938112262
   PubMed Web of Science ®Google Scholar
• BurneoJGTellez-ZentenoJWiebeSUnderstanding the burden of epilepsy in Latin America: a systematic review of its prevalence and incidenceEpilepsy Res2005661–3637416125900
   PubMed Web of Science ®Google Scholar
• PreuxPMDruet-CabanacMEpidemiology and aetiology of epilepsy in sub-Saharan AfricaLancet Neurol200541213115620854
   PubMed Web of Science ®Google Scholar
• MacTLTranDSQuetFOdermattPPreuxPMTanCTEpidemiology, aetiology, and clinical management of epilepsy in Asia: a systematic reviewLancet Neurol20076653354317509488
   PubMed Web of Science ®Google Scholar
• Center for Drug Evaluation and ResearchGuidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products – General ConsiderationsWashington, DCFood and Drug Administration, US Department of Health and Human Services2003 Available from: http://www.fda.gov/downloads/Drugs/Guidances/ucm070124.pdfAccessed September 12, 2014
   Google Scholar
• Committee for Medicinal Products for Human Use.Guideline on the Investigation of BioequivalenceLondonEuropean Medicines Agency2010 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdfAccessed September 12, 2014
   Google Scholar
• wma.net [homepage on the Internet]World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjectsWorld Medical Association2013 [cited September 12, 2014]. Available from: http://www.wma.net/en/30publications/10policies/b3/Accessed March 11, 2015
   Google Scholar
• ICH Expert Working GroupGuideline for Good Clinical Practice – ICH Harmonised Tripartite GuidelineGenevaInternational Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use1996 Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdfAccessed September 12, 2014
   Google Scholar
• Chemicals Group and Management Committee, Environment DirectorateOECD Series on Principles of Good Laboratory Practice and Compliance Monitoring, Number 1 – OECD Principles on Good Laboratory PracticeParisOrganisation for Economic Co-operation and Development1998 Available from: http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/mc/chem(98)17&doclanguage=enAccessed September 12, 2014
   Google Scholar
• DixonWJMasseyFJIntroduction to Statistical Analysis3rd edNew York, NYMcGraw-Hill1969
   Google Scholar
• MandalUSarkarAKGowdaKVDetermination of pregabalin in human plasma using LC-MS/MSChromatographia2008673–4237243
   Web of Science ®Google Scholar
• QuiñonesLSassoJTamayoEA comparative bioavailability study of two formulations of pregabalin in healthy Chilean volunteersTher Adv Chronic Dis20101414114823251735
   PubMedGoogle Scholar
• Badan Pengawas Obat dan Makanan Republik Indonesia (BPOM RI)Pedoman uji bioekivalensi [Guideline for bioequivalence studies]JakartaBPOM RI2004 Bahasa. Available from: http://jdih.pom.go.id/produk/PERATURANKEPALABPOM/PERKBPOM_NO.HK.00.05.3.1818TH2005_TentangPEDOMANUJIBIOEKIV_2005.pdfAccessed March 30, 2015
   Google Scholar
• KesselheimASMisonoASLeeJLClinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysisJAMA2008300212514252619050195
   PubMed Web of Science ®Google Scholar
• ThiessenJJChapter 8: Bioavailability and bioequivalencedu SouichPOrmeMErillSThe IUPHAR Compendium of Basic Principles for Pharmacological Research in HumansKansas City, KSInternational Union of Pharmacology (IUPHAR)20045566 Available from: http://www.iuphar.org/pdf/hum_55.pdfAccessed September 12, 2014
   Google Scholar
• JangKHSeoJHYimSVLeeKTRapid and simple method for the determination of pregabalin in human plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS): application to a bioequivalence study of Daewoong pregabalin capsule to Lyrica® capsule (pregabalin 150 mg)J Pharm Invest2011414255262
   Google Scholar
• Center for Veterinary MedicineGuidance for industry: Bioequivalence GuidanceWashington, DCFood and Drug Administration, US Department of Health and Human Services2006 Available from: http://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/ucm052363.pdfAccessed September 12, 2014
   Google Scholar
• Arenas-GuzmanRTostiAHayRHanekeENational Institute for Clinical ExcellencePharmacoeconomics – an aid to better decision-makingJ Eur Acad Dermatol Venereol200519Suppl 1S34S39
   PubMed Web of Science ®Google Scholar
• TraskLSPharmacoeconomics: principles, methods, and applicationsDiPiroJTTalbertRLYeeGCMatzkeGRWellsBGPoseyMPharmacotherapy: A Pathophysiologic Approach8th edNew YorkMcGraw-Hill Global Education Holdings Available from: http://accesspharmacy.mhmedical.com/content.aspx?bookid=462&sectionid=41100767Accessed February 26, 2015
   Google Scholar
• DilettiEHauschkeDSteinijansVWSample size determination for bioequivalence assessment by means of confidence intervalsInt J Clin Pharmacol Ther Toxicol1991291182004861
   PubMed Web of Science ®Google Scholar